DUBLIN--(BUSINESS WIRE)--The new research portal is an invaluable resource for anyone seeking company research on Teva Pharmaceuticals and their activities within the generic drug, active pharmaceutical ingredient and proprietary pharmaceuticals markets, providing comprehensive research on their market position, competitor activity and their future outlook within these markets.
One such research report available on the portal, Active Pharmaceutical Ingredients (API) Market Size and Forecast, expects the API market to reach a value of USD 239.8 billion by 2025. The rising prevalence of lifestyle-induced & age-related diseases and cancer is projected to drive the market over the forecast period. Advancements in recombinant molecular technologies and high capitalization for development of novel drugs are also estimated to boost growth.
“The portal provides visitors with unparalleled access to company research on Teva Pharmaceuticals, enabling them to track the company’s performance and impact on the various markets in which it is currently engaged,” says Ross Glover, CEO of Research and Markets.
For more information visit http://www.researchandmarkets.com/companies/teva-pharmaceutical-industries-ltd?cid=bgsldx
About Research and Markets
Research and Markets is the world's leading market research store.
With more than 1.5 million research resources, we deliver the largest collection of business information products on the market. We offer the most in-depth market analysis across a multitude of industries. Our products provide clients with an unrivalled understanding of their chosen market. No matter how specialist your field, we have the insights and market data to help you make efficient and effective decisions.